Safety and Efficacy of HMI-203 in ERT-Treated Adults With MPS II - NCT05238324

Evaluate the incidence and severity of adverse events of special interest (AESIs) and serious adverse events (SAEs) of a single dose administration of HMI-203 (at each dose level) in adult participants with MPS II, Assess long-term safety of HMI-203 in single administration in adult participants with MPS II by monitoring changes in 12-lead electrocardiograms (ECGs), Assess long-term safety of HMI-203 in single administration by monitoring body temperature., (and 20 more...)